RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Imatinib mesylate in desmoplastic small round cell tumour
2012-01-01 Bertuzzi, A; Bisogno, G; Carli, M; Ferrari, A; Comandone, A; Gasco, M; De Sanctis, R; Gnocchi, C; Santoro, A
IMPACT OF SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS (STNF-RS) SHEDDING ON OUTCOME IN PATIENTS TREATED WITH NGR-HTNF
2012-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Santoro, A; Lambiase, A; Bordignon, C
KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL)
2020-01-01 Kuruvilla, John; Ramchandren, Radhakrishnan; Santoro, Armando; Paszkiewicz-Kozik, Ewa; Gasiorowski, Robin; Johnson, Nathalie; Melnichenko, Vladimir; Maria Fogliatto, Laura; Goncalves, Iara; de Oliveira, Jose; Buccheri, Valeria; Fleury Perini, Guilherme; Goldschmidt, Neta; Alekseev, Sergey; Kryachok, Iryna; Sekiguchi, Naohiro; Zhu, Ying; Nahar, Akash; Marinello, Patricia; Luigi Zinzani, Pier
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T).
2013-01-01 De Sanctis, R; Quagliuolo, V; Viganò, A; Lutman, Fr; Bertuzzi, Af; Marchetti, S; Zucali, Pa; Santoro, A
NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM)
2011-01-01 De Vincenzo, F; Rossoni, G; Santoro, A; Gregorc, V; Zucali, Pa; Citterio, G; Simonelli, M; Petrella, G; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Oocytes Cryopreservation in Oncological Patients: Experience of a Tertiary Care Referral Center
2015-01-01 Baggiani, A; Albani, E; Specchia, C; Smeraldi, A; Tinterri, C; Santoro, A; Levi Setti, Pe
Outcome evaluation of patients with diagnosed WHO grade III glioma treated according to the molecular profile, the hystology, and the extent of resection (EOR)
2016-01-01 Navarria, P; Pessina, F; Bello, L; Ascolese, Am; DE ROSE, F; D'Agostino, Gr; Franzese, C; Comito, T; Bizzi, A; Simonelli, M; Santoro, A; Cozzi, L; Tomatis, S; Scorsetti, M
Pharmacodynamic (PD) evaluation of soluble proteins from a phase I trial of lapatinib (L) in combination with sorafenib (S)
2012-01-01 Simonelli, M; Zucali, Pa; Lorenzi, E; Rubino, L; De Vincenzo, F; Perrino, M; Rimassa, L; Giordano, L; Santoro, A
Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control
2014-01-01 Simonelli, M; Denlinger, Cs; Goff, Lw; Noberasco, C; Kim, Ty; Thomas, Mb; De Braud, Fg; Zucali, Pa; Santoro, A; English, Pa; Gallo-Stampino, C; Wang, Ej; Carpentieri, M; Williams, Ja
Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with solid tumors
2011-01-01 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Imatinib mesylate in desmoplastic small round cell tumour | 1-gen-2012 | Bertuzzi, A; Bisogno, G; Carli, M; Ferrari, A; Comandone, A; Gasco, M; De Sanctis, R; Gnocchi, C; Santoro, A | |
| IMPACT OF SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS (STNF-RS) SHEDDING ON OUTCOME IN PATIENTS TREATED WITH NGR-HTNF | 1-gen-2012 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Santoro, A; Lambiase, A; Bordignon, C | |
| KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL) | 1-gen-2020 | Kuruvilla, John; Ramchandren, Radhakrishnan; Santoro, Armando; Paszkiewicz-Kozik, Ewa; Gasiorowski, Robin; Johnson, Nathalie; Melnichenko, Vladimir; Maria Fogliatto, Laura; Goncalves, Iara; de Oliveira, Jose; Buccheri, Valeria; Fleury Perini, Guilherme; Goldschmidt, Neta; Alekseev, Sergey; Kryachok, Iryna; Sekiguchi, Naohiro; Zhu, Ying; Nahar, Akash; Marinello, Patricia; Luigi Zinzani, Pier | |
| Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). | 1-gen-2013 | De Sanctis, R; Quagliuolo, V; Viganò, A; Lutman, Fr; Bertuzzi, Af; Marchetti, S; Zucali, Pa; Santoro, A | |
| NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM) | 1-gen-2011 | De Vincenzo, F; Rossoni, G; Santoro, A; Gregorc, V; Zucali, Pa; Citterio, G; Simonelli, M; Petrella, G; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
| Oocytes Cryopreservation in Oncological Patients: Experience of a Tertiary Care Referral Center | 1-gen-2015 | Baggiani, A; Albani, E; Specchia, C; Smeraldi, A; Tinterri, C; Santoro, A; Levi Setti, Pe | |
| Outcome evaluation of patients with diagnosed WHO grade III glioma treated according to the molecular profile, the hystology, and the extent of resection (EOR) | 1-gen-2016 | Navarria, P; Pessina, F; Bello, L; Ascolese, Am; DE ROSE, F; D'Agostino, Gr; Franzese, C; Comito, T; Bizzi, A; Simonelli, M; Santoro, A; Cozzi, L; Tomatis, S; Scorsetti, M | |
| Pharmacodynamic (PD) evaluation of soluble proteins from a phase I trial of lapatinib (L) in combination with sorafenib (S) | 1-gen-2012 | Simonelli, M; Zucali, Pa; Lorenzi, E; Rubino, L; De Vincenzo, F; Perrino, M; Rimassa, L; Giordano, L; Santoro, A | |
| Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control | 1-gen-2014 | Simonelli, M; Denlinger, Cs; Goff, Lw; Noberasco, C; Kim, Ty; Thomas, Mb; De Braud, Fg; Zucali, Pa; Santoro, A; English, Pa; Gallo-Stampino, C; Wang, Ej; Carpentieri, M; Williams, Ja | |
| Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with solid tumors | 1-gen-2011 | Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ... 47
- 4 Contributo in Atti di Convegno ... 35
- 4 Contributo in Atti di Convegno ... 10
- 4 Contributo in Atti di Convegno ... 2
Data di pubblicazione
- 2020 - 2022 5
- 2010 - 2019 34
- 2005 - 2009 8
Rivista
- JOURNAL OF CLINICAL ONCOLOGY 19
- ANNALS OF ONCOLOGY 11
- EUROPEAN JOURNAL OF CANCER 2
- EUROPEAN JOURNAL OF CANCER. SUPPL... 2
- JOURNAL OF THORACIC ONCOLOGY 2
- CANCER RESEARCH 1
- EUROPEAN ASSOCIATION OF NEUROONCO... 1
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 1
- INTERNATIONAL JOURNAL OF RADIATIO... 1
- NEURO-ONCOLOGY 1
Lingua
- eng 7
- ita 1
Accesso al fulltext
- no fulltext 47